NCT02586207 2025-10-07
Pembrolizumab in Combination With CRT for LA-SCCHN
Sanford Health
Phase 1 Completed
Sanford Health
UNICANCER
University of California, San Francisco
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center